EyeWorld Weekly, November 21, 2025

➤ 510(k) clearance granted to auto kerato-refracto tonometer ➤ First patient dosed with gene therapy for Best disease ➤ Long-term data shows therapy delays geographic atrophy progression ➤ Lead gene therapy candidate to treat wet AMD and DME announced ➤ FDA accepts BLA resubmission ➤ Company news ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, November 21, 2025